ALPS Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-36,829
| Closed | -$2.51M | – | 1114 |
|
|
2022
Q3 | $2.51M | Sell |
36,829
-1,791
| -5% | -$122K | 0.02% | 263 |
|
|
2022
Q2 | $1.23M | Buy |
+38,620
| New | +$1.23M | 0.01% | 426 |
|
|
2021
Q4 | – | Sell |
-76,497
| Closed | -$1.95M | – | 1001 |
|
|
2021
Q3 | $1.95M | Sell |
76,497
-5,014
| -6% | -$128K | 0.02% | 321 |
|
|
2021
Q2 | $2.86M | Sell |
81,511
-30,284
| -27% | -$1.06M | 0.03% | 228 |
|
|
2021
Q1 | $4.56M | Buy |
111,795
+885
| +0.8% | +$36.1K | 0.04% | 182 |
|
|
2020
Q4 | $4.8M | Buy |
110,910
+32,659
| +42% | +$1.41M | 0.05% | 179 |
|
|
2020
Q3 | $4.32M | Sell |
78,251
-4,877
| -6% | -$269K | 0.06% | 169 |
|
|
2020
Q2 | $5.25M | Sell |
83,128
-26,109
| -24% | -$1.65M | 0.07% | 150 |
|
|
2020
Q1 | $5.58M | Sell |
109,237
-12,134
| -10% | -$620K | 0.09% | 139 |
|
|
2019
Q4 | $9.65M | Buy |
121,371
+1,730
| +1% | +$138K | 0.08% | 118 |
|
|
2019
Q3 | $5.81M | Buy |
119,641
+1,969
| +2% | +$95.5K | 0.05% | 136 |
|
|
2019
Q2 | $6.19M | Sell |
117,672
-16,451
| -12% | -$865K | 0.05% | 144 |
|
|
2019
Q1 | $7.1M | Buy |
134,123
+5,798
| +5% | +$307K | 0.05% | 139 |
|
|
2018
Q4 | $5.27M | Buy |
128,325
+36,213
| +39% | +$1.49M | 0.04% | 148 |
|
|
2018
Q3 | $3.5M | Buy |
92,112
+17,396
| +23% | +$661K | 0.02% | 191 |
|
|
2018
Q2 | $3.38M | Buy |
74,716
+13,010
| +21% | +$588K | 0.02% | 196 |
|
|
2018
Q1 | $2.98M | Buy |
61,706
+13,283
| +27% | +$641K | 0.02% | 183 |
|
|
2017
Q4 | $1.91M | Buy |
48,423
+5,408
| +13% | +$213K | 0.01% | 201 |
|
|
2017
Q3 | $1.34M | Buy |
43,015
+3,649
| +9% | +$113K | 0.01% | 217 |
|
|
2017
Q2 | $1.08M | Buy |
39,366
+2,874
| +8% | +$78.6K | 0.01% | 222 |
|
|
2017
Q1 | $1.35M | Buy |
36,492
+631
| +2% | +$23.3K | 0.01% | 195 |
|
|
2016
Q4 | $518K | Buy |
+35,861
| New | +$518K | ﹤0.01% | 370 |
|